שולי רווח נקי: NeurAxis Inc (NRXS)

NeurAxis, Inc. (NRXS) relies on third-party chip suppliers, completing the device configuration independently. Historical sales margins reflect profitability trends, where the -197.00 mark indicates the level of cost efficiency. However, the strategy of betting on organic growth via insurance codes without mergers, combined with diversification into the pediatric GI segment, creates certain risks of dependence on narrow market niches.
פילוחי מדדים מקיפים ואנליטיקה עבור NeurAxis Inc (NRXS)

The net profit margin of NeurAxis, Inc. (NRXS) evaluates the efficiency of converting revenue into bottom-line income. This ratio is calculated as net income divided by total sales. By analyzing the final sales margin, an investor gains a real-time assessment of capital density without time lags. For NeurAxis, Inc. (NRXS), this metric reflects the monetization of its innovative non-pharmacological treatment method for pediatric pain. The trend of this metric confirms financial stability during the implementation of the IB-Stim standard.